MYLAN SWINGS TO 3Q LOSS ON MEDICAID SETTLEMENT; VIEWS BEAT
October 29, 2009
Mylan Inc. (MYL) swung to a third-quarter loss due to its $121 million settlement of a Medicaid-rebate case, masking higher generic drug revenue.
Full Story Below
Rapid Response
Free Case Evaluation
The Help You Need,
When You Need it Most
More from Settlement News Directory
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
